Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19-Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance - Nine States, June-August 2021.
MMWR Morb Mortal Wkly Rep
; 70(37): 1291-1293, 2021 09 17.
Artigo
em Inglês
| MEDLINE | ID: covidwho-1441399
ABSTRACT
Data on COVID-19 vaccine effectiveness (VE) since the B.1.617.2 (Delta) variant of SARS-CoV-2, the virus that causes COVID-19, became the predominant circulating strain in the United States are limited (1-3). CDC used the VISION Network* to examine medical encounters (32,867) from 187 hospitals and 221 emergency departments (EDs) and urgent care (UC) clinics across nine states during June-August 2021, beginning on the date the Delta variant accounted for >50% of sequenced isolates in each medical facility's state. VISION Network methods have been published (4).
Texto completo:
Disponível
Coleções:
Bases de dados internacionais
Base de dados:
MEDLINE
Assunto principal:
Vacinas contra COVID-19
/
SARS-CoV-2
/
COVID-19
Tipo de estudo:
Estudo experimental
/
Estudo observacional
Tópicos:
Vacinas
/
Variantes
Limite:
Adolescente
/
Adulto
/
Idoso
/
Humanos
/
Meia-Idade
/
Jovem adulto
País/Região como assunto:
América do Norte
Idioma:
Inglês
Revista:
MMWR Morb Mortal Wkly Rep
Ano de publicação:
2021
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS